A proprietary, modular architecture that seamlessly integrates data processing, advanced feature engineering, and automated ML training into a universal pipeline.
Our patent-pending MetaLine pipeline consists of five integrated modules that work together to deliver unprecedented accuracy and efficiency.
Universal data ingestion supporting multiple biomarker types: histopathology images, RNASeq, proteomics, genomics, metabolomics, and clinical data.
Automated extraction of relevant features from raw data using domain-specific algorithms and deep learning techniques tailored to each biomarker type.
Our breakthrough innovation: stochastic coordinate transformations and deep feature networks that map complex, high-dimensional data into optimized representations for ML training.
Patent Pending: This proprietary mapping technique is the core of our competitive advantage
Automated machine learning with ensemble methods, hyperparameter optimization, cross-validation, and model selection to ensure optimal predictive performance.
Comprehensive evaluation and reporting with accuracy metrics, ROC curves, confusion matrices, feature importance analysis, and clinical interpretation guidelines.
MetaML AI leverages cutting-edge techniques and proprietary innovations to deliver superior performance across all biomarker types.
Our proprietary algorithm transforms high-dimensional biomarker spaces into optimized coordinate systems that maximize signal-to-noise ratios and improve model training.
Multi-layer neural architectures extract hierarchical representations from complex biomarker data, capturing both local and global patterns.
The system automatically selects and configures optimal processing pipelines based on data characteristics, eliminating manual parameter tuning.
Alzheimer's Detection
ADNI plasma biomarkers
Cancer Immunotherapy
Dataset successfully analyzed
vs. Months
Time to deployment